# Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI

> **NCT02848560** · — · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 38 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Hyperpolarized Xenon

## Key facts

- **NCT ID:** NCT02848560
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-03
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02848560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02848560, "Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02848560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*